CLINICAL_TRIALS
research
· 2025-01-10
Clinical Trial Update: A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer [Phase 2, Phase 3]
Summary
A randomized study is evaluating neoadjuvant radiotherapy with systemic therapy for early-stage breast cancer in Phase 2/Phase 3, with recruitment not yet start…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Xijing Hospital | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING